Huma is the new name for Medopad as it makes acquisitions in its quest to make preventative healthcare a reality.
Recursion Pharmceuticals has closed a $121 million Series C funding round, led by Scottish Mortgage Investment Trust, with participation from new and all prior institutional investors. The funds will be invested to continue building Recursion’s AI-enabled drug discovery platform, as well as to develop capabilities to accelerate new chemical entity chemistry and predict safety pharmacology. Recursion […]
AI is being deployed in the NHS to improve healthcare delivery across a broad range of activities
There isn’t any aspect of healthcare that isn’t being transformed by technology. The health-related technologies on display reflected the work that is being done to prevent illness, to deliver more effective treatments, and to reduce the growing cost of healthcare.
Ablacon, which is developing an atrial fibrillation (AFib) mapping system, has closed a $21.5 million Series A funding round led by Ajax Health.
Deep Lens, an AI-enabled clinical trial recruitment platform, has closed a $14 million Series A round led by Northpond Ventures, with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners.
TriNetX, a clinical research network, has closed its Series D investment round of $40 million led by Merck GHIF. The funding will be used for international expansion and product development.
MMC Ventures, which invests in AI companies, has published its State of AI 2019 report, revealing rapid recent progress in AI adoption in healthcare.
The Global Commission to End the Diagnostic Odyssey for Children has today published recommendations on how to solve the challenge of diagnosing rare diseases. The commission was set up by Takeda, Microsoft, and EURORDIS-Rare Diseases Europe to find solutions to core barriers preventing timely diagnosis for rare diseases.
At HIMSS19, one theme seems to filter through all the buzz and activity: delivering value-based, patient-centred care.